The NIH is actively seeking input for its next five-year strategic plan. Don’t miss out on this opportunity.
Too many babies with treatable conditions fall through the cracks of our inconsistent newborn screening programs. Can genomics help?
A bipartisan bill in the current session of Congress aims to redefine patent eligibility in a way that could be devastating for patients in the era of genetic medicine.
If you’ve gotten genetic test results (or you might get one in the future), you should know what goes on behind the scenes to bring you that report.
Plus: An important opportunity to share your feedback about scientific research priorities with the NIH
Also this week: new insights into long Covid, reducing HIV infections, and what makes our cells tick
From slashed funding to an FDA playing politics, we are at risk of losing the best tools we have for staying safe.
New technologies make it possible to test drug candidates faster, and avoid costly clinical trials for drugs that won’t make it to market
Trillions of bacteria, viruses, and fungi call us home — and some of them keep us healthier.
In other news, scientists eavesdrop on cellular activity, and the U.S. public health situation declines
Key takeaways about the promising new report from the American Cancer Society
As genetic tests boom, scientists at the NIH asked how comfortable we are with the concepts needed to understand those results.
